Para pacientes que viven con obesidad o diabetes tipo 2, contar con una alternativa oral de alta eficacia podra ser una autntica revolucin
Loghin, Effects of renal impairment on the pharmacokinetics of the dual GIP and GLP-1 receptor agonist tirzepatide
Scott TL, Wicker CA, Suganya R, Dhar B, Pittman T, Horbinski C, et al
Last Updated: April 4, 2026 | Reading Time: Approximately 8 minutes | Author: Palmetto Peptides Research Team Quick Answer When researchers move beyond native IGF-1 and begin evaluating synthetic analogs for preclinical work, two peptides come up consistently: IGF-1 LR3 and IGF-1 DES
Supplied as a stable 20mg lyophilized vial
10.1038/nm1233 175 Skrzyska-DziduszkoK